Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
Community Health Systems
CYH
$423M
| $2.53M | ﹤0.01% |
56,870
+24,200
| +74% | +$1.04M |
|
|
SQBK
2527
DELISTED
SQUARE 1 FINANCIAL INC COM
SQBK
| $2.53M | ﹤0.01% |
102,594
+6,740
| +7% | +$143K |
|
2528
PUT
Royal Bank of Canada
RY
$301B
| $2.53M | ﹤0.01% |
36,600
-35,200
| -49% | -$2.49M |
|
|
AAT
2529
American Assets Trust
AAT
$1.4B
| $2.53M | ﹤0.01% |
63,469
+23,820
| +60% | +$902K |
|
|
PRE
2530
PUT
DELISTED
PARTNERRE LTD
PRE
| $2.52M | ﹤0.01% |
22,100
+13,100
| +146% | +$1.49M |
|
|
NAV
2531
CALL
DELISTED
Navistar International
NAV
| $2.52M | ﹤0.01% |
75,300
+11,700
| +18% | +$403K |
|
2532
PUT
Puma Biotechnology
PBYI
$456M
| $2.52M | ﹤0.01% |
13,300
-8,100
| -38% | -$1.8M |
|
|
SGMO
2533
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.51M | ﹤0.01% |
165,282
+22,553
| +16% | +$274K |
|
|
CORE
2534
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.51M | ﹤0.01% |
81,086
+50,542
| +165% | +$1.47M |
|
2535
CALL
Arista Networks
ANET
$251B
| $2.51M | ﹤0.01% |
660,800
+152,000
| +30% | +$705K |
|
|
KS
2536
DELISTED
KapStone Paper and Pack Corp.
KS
| $2.51M | ﹤0.01% |
85,509
+4,508
| +6% | +$131K |
|
|
MLNX
2537
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.5M | ﹤0.01% |
58,500
-41,900
| -42% | -$1.82M |
|
|
MW
2538
CALL
DELISTED
THE MENS WAREHOUSE INC
MW
| $2.5M | ﹤0.01% |
56,600
+38,100
| +206% | +$1.72M |
|
|
IMOS
2539
ChipMOS TECHNOLOGIES
IMOS
$2.03B
| $2.5M | ﹤0.01% |
97,198
+58,027
| +148% | +$1.39M |
|
|
SPLS
2540
PUT
DELISTED
Staples Inc
SPLS
| $2.49M | ﹤0.01% |
137,500
-227,800
| -62% | -$3.18M |
|
|
NPSP
2541
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $2.49M | ﹤0.01% |
69,600
-20,900
| -23% | -$624K |
|
2542
CALL
Lamar Advertising Co
LAMR
$15.8B
| $2.49M | ﹤0.01% |
46,400
+2,800
| +6% | +$145K |
|
2543
CALL
Genworth Financial
GNW
$3.84B
| $2.48M | ﹤0.01% |
292,300
+92,200
| +46% | +$968K |
|
2544
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $2.48M | ﹤0.01% |
20,848
+19,767
| +1,829% | +$2.43M |
|
2545
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
| $2.48M | ﹤0.01% |
39,558
+5,438
| +16% | +$319K |
|
2546
CALL
Cintas
CTAS
$79.8B
| $2.48M | ﹤0.01% |
126,400
-53,600
| -30% | -$968K |
|
|
BKS
2547
PUT
DELISTED
Barnes & Noble
BKS
| $2.48M | ﹤0.01% |
162,824
+86,371
| +113% | +$1.23M |
|
2548
CALL
Microchip Technology
MCHP
$43B
| $2.48M | ﹤0.01% |
109,800
+12,800
| +13% | +$278K |
|
|
HERO
2549
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $2.47M | ﹤0.01% |
2,466,070
+2,340,984
| +1,871% | +$3.42M |
|
2550
CALL
Affiliated Managers Group
AMG
$9.89B
| $2.46M | ﹤0.01% |
11,600
-4,100
| -26% | -$814K |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.